Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001033427-09-000026
Filing Date
2009-02-04
Accepted
2009-02-04 09:49:21
Documents
1
Group Members
BANCIRELAND (US) HOLDINGS, INC.BIAM (US) INC.BIAM HOLDINGSIRIDIAN ASSET MANAGAMENT LLCTHE GOVERNOR AND COMPANY OF THE BANK OF IRELAND

Document Format Files

Seq Description Document Type Size
1 enzonpharm13ga2123108.txt SC 13G/A 22560
  Complete submission text file 0001033427-09-000026.txt   24979
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35587 | Film No.: 09567029
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST RD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Filed by) CIK: 0001033427 (see all company filings)

EIN.: 061439577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A